『VerifiedRx』のカバーアート

VerifiedRx

VerifiedRx

著者: Vizient Center for Pharmacy Practice Excellence
無料で聴く

このコンテンツについて

Delivering short doses of insight for hospitals’ frontline pharmacy professionals, the Vizient pharmacy team brings together experts to verify best practices for navigating today’s pharmacy practice challenges and accelerating career growth. It’s a prescription for success, delivered by the Vizient Center for Pharmacy Practice Excellence.Copyright 2025 All rights reserved. マネジメント マネジメント・リーダーシップ 科学 経済学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Built to Last: Rx for Resilience
    2025/06/24

    We all know that clinician burnout negatively impacts the quality of patient care. That's why pharmacy residency accrediting bodies now emphasize resident well-being and professional sustainability as core components of residency training earlier in clinician careers. The American Society of Health-System Pharmacists (ASHP) Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies include a formal requirement for programs to address resilience, well-being, and burnout prevention, reflecting the increasing recognition of burnout in healthcare. Joining us to talk that out are Tony Huke, Senior Pharmacy Executive Director with Vizient Pharmacy Advisory Solutions and Kendra Gage, Inpatient Clinical Pharmacist and the PGY 1 Residency Program Director at UCHealth, University of Colorado Hospital in Aurora, Colorado.

    Guest speakers:

    Tony Huke, PharmD, BCPS, FASHP

    Senior Pharmacy Executive Director

    Vizient Pharmacy Advisory Solutions

    Kendra Gage, PharmD, BCPS

    Inpatient Clinical Pharmacist

    PGY1 Pharmacy Residency Program Director

    UCHealth

    Host:

    Kerry Schwarz, PharmD, MPH

    Senior Clinical Manager, Evidence-Based Medicine and Outcomes

    Center for Pharmacy Practice Excellence (CPPE)

    Show Notes:

    [01:11-03:25] What’s new at the national level in terms of pharmacy resident resiliency and well-being

    [03:26-03:56] The intentionality of well-being in pharmacy residency programs

    [03:57-05:12] Examples from Kendra’s program

    [05:13-06:40] Program expectations to address resilience

    [06:41-08:33] Assessment and potential metrics of resiliency programs

    [08:34-11:06] The role of pharmacy leadership and residency program directors in resiliency

    [11:07-12:34] Impact of resiliency programs so far

    Links | Resources:

    Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies

    Subscribe Today!

    Apple Podcasts

    Amazon Podcasts

    Spotify

    Android

    RSS Feed

    続きを読む 一部表示
    13 分
  • COVID Vaccine Realities for 2025–26
    2025/06/12

    Information on COVID vaccines is moving fast. On May 27th, HHS Secretary Robert F. Kennedy Jr. announced that COVID vaccines will no longer be universally recommended for healthy children or healthy pregnant women. That's a big shift, and understandably, it's raised a lot of questions. We're going to cut through the noise and take a look at where things really stand, who's getting vaccinated, how current guidance is evolving, and what this means for both children and adults as we look ahead to the next respiratory season. Joining us to help sort it all out is Dr. John Schoen, Senior Clinical Manager of Drug Information at Vizient.

    Guest speakers:

    John Schoen, PharmD, BCPS

    Senior Clinical Manager of Drug Information

    Vizient Center for Pharmacy Practice Excellence

    Host:

    Stacy Lauderdale, PharmD, BCPS

    Associate Vice President

    Vizient Center for Pharmacy Practice Excellence

    Show Notes:

    [01:38-05:32] What changed in the recent CDC update for healthy children

    [05:33-09:32] Discussion of COVID-19 outcomes and vaccination in children

    [09:33-11:47] Specific risk factors for pediatric patients

    [11:48-12:47] Is the US an outlier for not universally recommending the COVID-19 vaccine for healthy children and making no recommendation in healthy pregnant women?

    [12:48-14:03] The FDA’s proposed regulatory framework for COVID-19 vaccine approval

    [14:04-15:18] FDA’s approach to implementing revised requirements for randomized controlled trials

    [15:19-16:57] Key discussion points from the May meeting of the Vaccines and Related Biological Products Advisory Committee

    [17:00-18:27] Topics requiring further clarification about COVID-19 vaccine

    Links | Resources:

    Vizient resources:

    • Minute Market Insight: Potential ACIP COVID-19 recommendation changes April 2025: https://www.vizientinc.com/download?342668
    • Minute Market Insight: May 2025 COVID-19 vaccine recommendation and policy updates: https://www.vizientinc.com/download?352336

    Additional resources:

    • FDA perspective piece published in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMsb2506929
    • ACIP meeting information: https://www.cdc.gov/acip/meetings/index.html
    • CDC childhood immunization schedule: https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html
    • CDC adult immunization schedule by medical condition: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html
    • CDC RESP-NET: https://www.cdc.gov/resp-net/dashboard/
    • WHO COVID-19 dashboard: https://data.who.int/dashboards/covid19/deaths
    • MMWR - COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months: https://www.cdc.gov/mmwr/volumes/73/wr/mm7338a1.htm?utm_source=chatgpt.com
    • MMWR – MIS-C, US 2023: https://www.cdc.gov/mmwr/volumes/73/wr/mm7310a2.htm

    Subscribe Today!

    Apple Podcasts

    Amazon Podcasts

    Spotify

    Android

    RSS Feed

    続きを読む 一部表示
    20 分
  • Reverse Distribution needs your attention
    2025/05/27

    Pharmacy reverse distributors play a key role in making pharmaceutical returns more efficient, helping with processing, financial settlements and delivering helpful data. They're in a unique spot to support efforts to prevent diversion, speed up inventory returns, and even contribute to sustainability goals. Kyle Hoelting, director of pharmacy supply assurance and stewardship at Vizient, along with Paige Ivey, senior national accounts director, and Houston Blankinship, senior director of customer experience for healthcare product operations at Inmar Intelligence join host Carolyn Liptak, pharmacy executive director in Vizient Center for Pharmacy Practice Excellence and host for today's conversation.

    Guest speakers:

    Kyle Hoelting, Pharm.D, BCPS Director, Pharmacy Supply Assurance & Stewardship Vizient Center for Pharmacy Practice Excellence

    Paige Ivey Senior National Accounts Director Inmar Intelligence

    Houston Blankenship Senior Director of Customer Experience for Healthcare Product Operations Inmar Intelligence

    Host: Carolyn Liptak, MBA, RPh Pharmacy Executive Director Vizient

    Show Notes:

    [01:05-03:33] Background for Kyle, Paige, Houston [03:34-05:10] How the pharmaceutical supply chain works and how everything is interconnected [05:10-09:32] How reverse distribution specifically supports pharmacy operations [09:33-11:16] How data that comes from reverse distribution can offer some great insights for pharmacy leaders [11:58-13:57] How data that comes from reverse distribution can give insight to drug shortages [13:58-16:42] Inmar's role with insight into drug shortages [16:43-21:05] Go-to resources for those wanting to explore more on stewardship and protective purchases

    Links | Resources:

    Drug shortage stewardship: A novel solution for an old problem

    Vizient Essential Medications List

    Vizient Key performance indicators for the management of drug shortages

    Subscribe Today!

    Apple Podcasts

    Amazon Podcasts

    Spotify

    Android

    RSS Feed

    続きを読む 一部表示
    22 分

VerifiedRxに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。